Cobalt-60 Market Size, Share, Growth, and Industry Analysis, By Type (Low Specific Activity, High Specific Activity), By Application (Medical Application, Industrial Application, Others), Regional Insights and Forecast From 2026 To 2035

Cobalt-60 Market Overview

The global cobalt-60 market size is forecasted to reach USD 550.48 Million by 2035 from USD 334.02 Million in 2026, growing at a steady CAGR of 5.7% during the forecast from 2026 to 2035.

The Cobalt-60 market remains a critical segment of the global isotope industry due to its extensive use in sterilization, radiotherapy, food irradiation, and industrial radiography. More than 45 million cubic meters of medical products are sterilized annually using gamma radiation generated from Cobalt-60 sources. Around 50% of single-use medical devices worldwide undergo radiation sterilization, with Cobalt-60 accounting for nearly 80% of gamma sterilization processes. Global nuclear reactors in Canada, Russia, Argentina, and China are major suppliers of Cobalt-60 isotopes. More than 220 industrial gamma irradiators currently operate worldwide, while over 13,000 radiotherapy units utilize cobalt-based radiation systems for cancer treatment and oncology applications.

The United States remains one of the largest users of Cobalt-60 isotopes due to strong healthcare infrastructure and advanced sterilization demand. More than 20 billion medical devices are sterilized annually in the country through gamma irradiation systems using Cobalt-60 sources. The U.S. healthcare sector operates over 120 radiation sterilization facilities, while approximately 500 hospitals continue using cobalt-based radiotherapy equipment for cancer management. Around 1.9 million new cancer cases were recorded in the United States during 2025, increasing the need for radiotherapy procedures utilizing high-energy gamma isotopes. Industrial radiography demand also expanded by 11% due to aerospace inspection activities and infrastructure modernization projects.

Key Findings

• Key Market Driver: More than 68% of healthcare sterilization procedures depend on gamma irradiation systems, while 74% of radiation sterilization facilities prefer cobalt-based isotopes because of 99% sterilization efficiency and 93% penetration effectiveness for high-density medical packaging.
• Major Market Restraint: Around 41% of isotope transportation operations face regulatory delays, while 38% of healthcare providers report concerns regarding radioactive material handling and 32% of facilities encounter security compliance restrictions during isotope procurement.
• Emerging Trends: Approximately 57% of irradiation facilities are integrating automated isotope handling systems, while 49% of manufacturers are adopting digital monitoring platforms and 44% of industrial users are shifting toward compact high-specific-activity cobalt sources.
• Regional Leadership: North America accounts for nearly 36% of global cobalt-based sterilization capacity, while Europe contributes 28% and Asia-Pacific holds 25% due to rapid healthcare expansion and rising food irradiation projects.
• Competitive Landscape: Around 62% of global isotope production is controlled by leading nuclear organizations, while 54% of commercial sterilization contracts are concentrated among major international suppliers operating multi-reactor production facilities.
• Market Segmentation: Medical applications contribute approximately 61% of total isotope consumption, industrial applications account for 29%, and food irradiation and research applications collectively represent 10% of the global cobalt-60 market.
• Recent Development: During 2025, more than 33% of isotope manufacturers expanded irradiation capacity, while 26% invested in advanced source encapsulation technologies and 21% increased production through reactor modernization initiatives.

Cobalt-60 Market Latest Trends

The Cobalt-60 market is experiencing substantial transformation due to rising healthcare sterilization demand, modernization of nuclear reactors, and increasing food safety regulations. Nearly 70% of global sterile medical products currently undergo radiation sterilization using gamma technologies. More than 400 million liters of pharmaceutical packaging materials are irradiated annually to maintain contamination-free distribution systems. In food processing, over 700,000 metric tons of agricultural products are treated through gamma irradiation every year to eliminate pathogens and extend shelf life. Automation has emerged as a major trend in the Cobalt-60 market. Approximately 52% of newly installed irradiation facilities utilize robotic source loading systems that reduce human exposure levels by 46%.

Smart dosimetry systems improved irradiation accuracy by 29% during 2024. Compact gamma irradiators also gained popularity in hospitals and laboratories, particularly in Asia-Pacific, where installations increased by 18%. Healthcare modernization continues influencing market expansion. More than 15,000 radiotherapy treatments are conducted daily worldwide using cobalt-based systems. Developing countries increasingly prefer cobalt radiotherapy because installation costs remain 37% lower than advanced linear accelerator systems. Industrial radiography applications also expanded by 13% in energy infrastructure projects, pipeline inspection, and aerospace component testing. Growing investments in nuclear isotope production reactors across Russia, China, and Argentina are strengthening long-term isotope supply stability.

Cobalt-60 Market Dynamics

DRIVER

"Rising demand for radiation sterilization in healthcare and pharmaceutical sectors"

The increasing need for sterile healthcare equipment remains the strongest growth driver in the Cobalt-60 market. More than 30 billion syringes, surgical gloves, catheters, and implantable devices require sterilization annually across global healthcare systems. Gamma irradiation based on Cobalt-60 provides penetration depths exceeding 45 centimeters, allowing sterilization of dense packaged products without heat damage. Around 78% of prepackaged medical devices prefer gamma sterilization because the process eliminates bacteria and viruses with effectiveness levels above 99.9%.

Pharmaceutical manufacturing growth has further accelerated isotope demand. Approximately 62% of biologic drug packaging facilities use gamma irradiation systems for contamination control. Hospitals in developing countries continue adopting cobalt-based radiotherapy systems because maintenance costs remain 31% lower than advanced electron-beam alternatives. Global oncology incidence also continues increasing, with over 20 million new cancer diagnoses recorded annually, supporting strong radiotherapy equipment demand. Expansion of single-use medical devices and biotechnology manufacturing facilities is expected to sustain isotope utilization in healthcare sterilization applications.

RESTRAINT

"Strict regulatory compliance and radioactive material transportation restrictions"

The Cobalt-60 market faces operational limitations due to stringent nuclear regulations and transportation controls. More than 45 countries require specialized licensing for isotope importation, storage, and disposal activities. Around 39% of isotope shipments experience customs delays exceeding 12 days because of radioactive material inspection procedures. Transportation insurance costs for cobalt-based materials increased by 24% during 2024 due to security and containment concerns.

Public concerns regarding radiation exposure also affect infrastructure approvals for new irradiation facilities. Nearly 28% of proposed gamma sterilization projects encounter delays related to environmental safety reviews and community opposition. Disposal of spent radioactive sources remains another challenge because more than 60% of used isotopes require long-term secure storage. Maintenance of shielding systems and compliance monitoring contributes approximately 18% of operational expenditure in irradiation centers. These factors create barriers for small-scale healthcare institutions and industrial operators considering cobalt-based irradiation technologies.

OPPORTUNITY

"Expansion of food irradiation and emerging healthcare infrastructure"

Food irradiation is becoming a major opportunity area for the Cobalt-60 market due to rising food safety awareness and increasing international trade regulations. More than 65 countries currently approve gamma irradiation for agricultural products, spices, seafood, and meat processing. Around 500,000 metric tons of spices are irradiated every year to reduce microbial contamination and insect infestation. Gamma irradiation extends shelf life of perishable foods by nearly 40%, reducing transportation losses in export markets.

Emerging healthcare infrastructure projects also create significant growth opportunities. More than 4,000 hospitals are under development across Asia-Pacific and Middle Eastern countries, increasing future sterilization demand. Public healthcare programs in Africa and Southeast Asia expanded cancer treatment capacity by 22% during 2025, encouraging installations of cobalt-based radiotherapy units. Compact irradiator systems suitable for regional laboratories and pharmaceutical packaging centers gained adoption because installation footprints decreased by 34%. Investments in domestic isotope production reactors by China and India are expected to strengthen regional supply chains and reduce dependency on imported sources.

CHALLENGE

"Limited isotope production capacity and reactor dependency"

The Cobalt-60 market faces a major challenge due to dependence on a limited number of nuclear reactors capable of isotope production. Fewer than 30 reactors worldwide currently produce commercial-grade Cobalt-60 isotopes. More than 48% of global supply originates from reactors located in Russia and Canada, increasing vulnerability to geopolitical disruptions and reactor maintenance shutdowns. During 2024, temporary reactor maintenance activities reduced global isotope availability by 11%.

Production expansion requires substantial infrastructure investments and strict nuclear safety approvals. Construction timelines for isotope-capable reactors frequently exceed 8 years, while licensing processes can extend beyond 5 years. Supply interruptions also affect healthcare sterilization providers because approximately 72% of irradiation facilities rely on long-term isotope replacement schedules. High-specific-activity cobalt production requires advanced neutron flux technology, limiting manufacturing capability to a small number of specialized nuclear operators. Rising energy costs and spent fuel management expenses continue increasing production complexity for isotope manufacturers worldwide.

Cobalt-60 Market Segmentation

The Cobalt-60 market is segmented by type and application based on isotope activity level and end-use industries. High specific activity Cobalt-60 accounts for nearly 64% of global demand due to strong usage in industrial irradiators and healthcare sterilization facilities. Low specific activity isotopes contribute 36% because of demand in research laboratories and small-scale radiography systems. By application, medical sterilization and radiotherapy represent 61% of overall consumption, while industrial radiography contributes 29%. Food irradiation, agricultural preservation, and scientific research collectively account for 10% of total market utilization. Increasing healthcare investments and industrial inspection standards continue influencing segmentation growth patterns globally.

By Type

Based on Type, the global market can be categorized into Low Specific Activity, High Specific Activity.

• Low Specific Activity: Low specific activity Cobalt-60 represents approximately 36% of the global market due to its usage in laboratory applications, educational research, and smaller industrial inspection systems. These isotopes typically operate in facilities requiring lower gamma intensity and controlled exposure conditions. Around 42% of universities conducting nuclear science programs utilize low-activity cobalt sources for radiation experiments and calibration systems. Small-scale radiography facilities in emerging countries increased adoption by 16% during 2025 because equipment costs remain 28% lower compared to high-specific-activity systems. Medical calibration procedures also support demand for low specific activity sources. More than 1,500 diagnostic laboratories globally utilize low-intensity gamma systems for dosimetry validation and radiation equipment testing. Industrial equipment manufacturers prefer these isotopes for compact inspection devices used in construction material testing and pipeline monitoring. Asia-Pacific accounts for nearly 31% of low specific activity demand due to expanding educational and industrial research infrastructure.

• High Specific Activity: High specific activity Cobalt-60 dominates nearly 64% of the global market because of extensive deployment in large-scale sterilization facilities and cancer radiotherapy centers. These isotopes provide stronger gamma emission and higher penetration efficiency for industrial and healthcare applications. More than 80% of commercial gamma irradiation facilities operate using high-specific-activity sources. Radiation sterilization centers processing over 500,000 cubic feet of medical products monthly rely heavily on these isotopes for rapid treatment cycles. High-specific-activity cobalt sources are also critical in oncology treatment systems. Approximately 13,000 radiotherapy units globally use cobalt isotopes to deliver targeted cancer therapy. Industrial radiography applications expanded by 14% due to rising infrastructure inspections in oil and gas pipelines, aerospace manufacturing, and heavy engineering sectors. North America contributes nearly 38% of high-specific-activity consumption due to extensive sterilization infrastructure and established healthcare manufacturing capacity.

By Application

• Medical Application: Medical applications account for approximately 61% of total Cobalt-60 consumption worldwide due to strong demand for sterilization and radiotherapy services. More than 50% of disposable medical devices globally are sterilized using gamma irradiation systems. Around 160 million surgical kits undergo cobalt-based sterilization annually to ensure microbial elimination exceeding 99.9%. Cancer treatment demand also supports market expansion, with over 20 million new oncology cases recorded globally during 2025. Hospitals in developing countries continue preferring cobalt radiotherapy units because operational maintenance expenses remain 33% lower than advanced accelerator technologies. More than 500 cobalt radiotherapy systems are active in North America alone. Pharmaceutical packaging sterilization increased by 19% due to expanding vaccine manufacturing and biologics production. Regulatory approvals for radiation sterilization of implantable devices and surgical products further strengthened medical sector adoption worldwide.

• Industrial Application: Industrial applications contribute nearly 29% of global Cobalt-60 demand, driven by radiography inspection and material testing requirements. More than 75,000 industrial radiography inspections are conducted every day using gamma-emitting isotopes for weld analysis, pipeline integrity monitoring, and aerospace component testing. Oil and gas infrastructure projects increased cobalt-based inspection demand by 17% during 2025. Manufacturing industries prefer Cobalt-60 radiography because gamma rays penetrate dense metals exceeding 20 centimeters in thickness. Around 48% of industrial radiography operations are concentrated in energy and petrochemical sectors. Automotive and aviation manufacturing facilities also expanded adoption of isotope-based nondestructive testing systems to reduce structural failure risks. Industrial irradiation systems used for polymer modification and material enhancement increased by 11%, particularly in Asia-Pacific manufacturing hubs.

• Others: Other applications account for approximately 10% of the Cobalt-60 market, including food irradiation, agricultural preservation, and scientific research. More than 700,000 metric tons of spices, grains, seafood, and meat products undergo gamma irradiation annually to eliminate bacteria and insects. Food irradiation reduces spoilage rates by nearly 35% and extends shelf life by up to 45 days for certain agricultural products. Research institutions and environmental laboratories also utilize cobalt isotopes for radiation studies and calibration procedures. Around 1,200 scientific facilities worldwide use cobalt sources for material irradiation experiments and biological testing. Agricultural applications increased by 13% during 2025 because export-oriented food producers adopted irradiation processes to meet international contamination standards. Governments in Asia and the Middle East continue investing in food safety infrastructure, supporting future demand in non-medical applications.

Cobalt-60 Market Regional Outlook

• North America

North America accounts for approximately 36% of global Cobalt-60 market consumption due to advanced healthcare systems and strong sterilization infrastructure. The region operates more than 90 commercial irradiation facilities that process billions of medical products annually. Nearly 52% of all sterile healthcare packaging in North America utilizes cobalt-based gamma irradiation. Canada remains a major isotope producer because nuclear reactors in Ontario contribute significant global supply volumes. The United States dominates regional demand with over 500 active cobalt radiotherapy systems and more than 120 gamma sterilization centers. Around 1.9 million new cancer cases reported during 2025 increased demand for radiotherapy procedures and oncology infrastructure.

Pharmaceutical packaging sterilization grew by 14% due to rising biologic drug manufacturing and vaccine production activities. Industrial radiography also supports regional growth. Approximately 40% of aerospace inspection procedures in North America use gamma-emitting isotopes for nondestructive testing. Oil pipeline maintenance and nuclear power plant inspections increased cobalt-based radiography demand by 12%. Investments in automation technologies improved irradiation facility throughput by 21%, while robotic source handling reduced worker radiation exposure by 37%. Regulatory oversight from nuclear safety authorities remains strict, but modernization initiatives continue strengthening long-term market stability across the region.

• Europe

Europe represents nearly 28% of global Cobalt-60 demand due to strong healthcare standards, industrial testing infrastructure, and food safety regulations. More than 70 irradiation facilities operate across Germany, France, the United Kingdom, and Eastern Europe. Around 46% of pharmaceutical packaging manufacturers in Europe utilize gamma sterilization systems to maintain contamination-free production. Cancer treatment demand remains a major market contributor. Approximately 4 million new cancer diagnoses are recorded annually across Europe, supporting radiotherapy installations and isotope utilization. More than 2,500 oncology centers use radiation-based treatment systems, with cobalt therapy units maintaining relevance in cost-sensitive healthcare facilities.

Industrial radiography applications also remain substantial. Europe conducts over 20 million weld inspections annually in aerospace, automotive, and energy infrastructure projects. Around 31% of industrial gamma inspection demand originates from offshore energy infrastructure and petrochemical operations. Food irradiation gained momentum during 2025, particularly in spice processing and seafood preservation sectors. Nuclear research organizations in France and Poland continue investing in isotope handling modernization and advanced shielding technologies. Approximately 18% of European irradiation facilities upgraded digital dosimetry systems during 2024 to improve treatment precision and regulatory compliance. Growing investments in sustainable healthcare sterilization infrastructure continue supporting regional market expansion.

• Asia-Pacific

Asia-Pacific holds approximately 25% of the global Cobalt-60 market and represents the fastest expanding regional consumer due to healthcare infrastructure growth and increasing food irradiation projects. China, India, Japan, and South Korea collectively operate more than 80 gamma irradiation facilities. Around 45% of newly constructed sterilization centers during 2025 were located in Asia-Pacific. China remains a major regional contributor through domestic isotope production and nuclear reactor expansion. More than 350 hospitals in China utilize cobalt-based radiotherapy systems for oncology treatment. India expanded healthcare sterilization capacity by 22% due to increasing pharmaceutical exports and medical device manufacturing activities.

Food irradiation is another major growth factor across Asia-Pacific. Nearly 300,000 metric tons of spices and agricultural products are irradiated annually to reduce contamination and extend export shelf life. Governments in Southeast Asia increased food safety inspections by 19%, encouraging adoption of gamma treatment technologies. Industrial demand also remains strong. Infrastructure development projects across India and China increased nondestructive testing procedures by 16%, particularly in oil pipelines, railways, and heavy manufacturing sectors. Investments in compact irradiation systems suitable for regional laboratories and pharmaceutical centers increased by 24%. Expansion of domestic isotope production reactors in China and India continues strengthening regional supply security and reducing dependence on imported sources.

• Middle East & Africa

The Middle East and Africa account for approximately 11% of the global Cobalt-60 market due to rising healthcare investments and expanding industrial infrastructure. More than 40 radiation processing facilities currently operate across the region, with increasing adoption in healthcare sterilization and food preservation applications. Countries including Saudi Arabia, South Africa, Egypt, and the United Arab Emirates continue investing in advanced oncology treatment systems. Cancer treatment infrastructure expanded significantly during 2025, with regional healthcare authorities increasing radiotherapy installations by 15%. Around 120 hospitals across the Middle East utilize cobalt-based radiotherapy equipment due to lower maintenance costs and operational reliability. Medical product sterilization demand also increased by 18% because of growth in pharmaceutical imports and domestic healthcare manufacturing.

Food irradiation gained importance in agricultural export markets. Approximately 70,000 metric tons of grains, fruits, and seafood products are irradiated annually to meet international food safety standards. Industrial radiography applications expanded by 13% in oil refining and petrochemical sectors, particularly in Gulf Cooperation Council countries. Government investments in nuclear research infrastructure also contributed to regional development. South Africa continues supporting isotope research through nuclear technology programs, while Gulf countries invested in radiation safety training and regulatory modernization. Rising urbanization and healthcare infrastructure expansion are expected to support future cobalt isotope demand across the region.

List of Top Cobalt-60 Companies

• Nordion
• China National Nuclear Corporation
• Rosatom
• Eckert & Ziegler Strahlen
• Polatom
• NTP
• DIOXITEK

Top 2 Companies with Highest Market Share

• Nordion holds approximately 34% of global commercial Cobalt-60 supply capacity due to strong reactor partnerships and extensive sterilization infrastructure support across North America, Europe, and Asia-Pacific.

• Rosatom accounts for nearly 27% of global isotope production through advanced reactor facilities and large-scale export operations supplying healthcare sterilization and industrial irradiation markets in more than 40 countries.

Investment Analysis and Opportunities

The Cobalt-60 market continues attracting investments due to increasing healthcare sterilization demand and expanding oncology treatment infrastructure. More than 25 isotope infrastructure projects were announced globally during 2024 and 2025, including reactor modernization programs and gamma irradiation facility expansions. Around 41% of investment activity focused on healthcare sterilization systems, while 28% targeted food irradiation infrastructure. Nuclear reactor upgrades remain a major investment area. Canada, Russia, China, and India collectively allocated significant resources toward enhancing isotope production capacity and improving neutron irradiation efficiency. Approximately 19 new gamma sterilization facilities entered construction during 2025 to support growing medical device manufacturing volumes.

Private-sector healthcare companies also increased investments in compact irradiation systems suitable for regional hospitals and pharmaceutical packaging facilities. Automation technology integration improved irradiation throughput by 23% while reducing operational labor requirements by 17%. Food safety regulations across Asia and the Middle East created new opportunities for agricultural irradiation facilities capable of processing more than 50,000 metric tons annually. Industrial radiography demand in aerospace and energy sectors also supports long-term investment opportunities. More than 60% of oil pipeline inspection contracts in developing markets now require gamma-based nondestructive testing. Rising healthcare expenditure, expanding pharmaceutical exports, and increasing cancer treatment demand continue creating attractive opportunities for isotope producers, sterilization operators, and radiation technology manufacturers.

New Product Development

New product development in the Cobalt-60 market focuses on safer isotope handling, improved irradiation efficiency, and compact system deployment. During 2025, approximately 37% of irradiation equipment manufacturers introduced automated source loading systems designed to reduce human radiation exposure by more than 40%. Advanced shielding materials with density improvements of 18% enhanced facility safety performance and operational reliability. Compact gamma irradiation units gained strong adoption among regional hospitals and research laboratories. These systems require installation space reductions of nearly 30% compared to older irradiation models. Smart dosimetry integration improved radiation precision by 26%, supporting more accurate sterilization cycles and medical treatment planning.

Manufacturers also developed corrosion-resistant isotope capsules capable of extending operational lifespan by 15 years. Around 22% of newly launched products included digital monitoring interfaces allowing real-time radiation tracking and predictive maintenance analysis. Portable industrial radiography devices using miniaturized cobalt sources expanded deployment in offshore energy projects and aerospace inspections. Food irradiation technology also experienced innovation growth. Multi-conveyor gamma treatment systems increased processing capacity by 20%, allowing faster handling of agricultural exports and packaged foods. Research organizations continue developing hybrid sterilization technologies combining gamma irradiation with automated contamination detection systems, improving productivity across healthcare and industrial applications.

Five Recent Developments (2023-2025)

• March 2023: Nordion expanded isotope processing operations in Canada, increasing Cobalt-60 source handling capacity by 14% to support growing medical sterilization demand across North America.
• September 2023: Rosatom completed modernization of reactor irradiation channels, improving isotope production efficiency by 19% and increasing export supply capabilities to more than 40 countries.
• February 2024: China National Nuclear Corporation launched a new gamma irradiation facility capable of processing 120,000 cubic meters of medical products annually for sterilization applications.
• July 2024: Eckert & Ziegler Strahlen introduced upgraded cobalt source encapsulation technology that improved radiation containment performance by 21% and extended operational durability.
• January 2025: Polatom expanded industrial radiography isotope distribution operations in Europe, increasing supply availability for energy infrastructure inspection projects by 16%.

Report Coverage of Cobalt-60 Market

The Cobalt-60 market report provides extensive analysis of isotope production, sterilization infrastructure, industrial radiography applications, and regional healthcare demand patterns. The study evaluates more than 30 commercial isotope production facilities and over 220 gamma irradiation centers operating worldwide. Market coverage includes analysis of reactor-based isotope manufacturing, radiotherapy systems, medical device sterilization, food irradiation, and industrial nondestructive testing applications. The report examines segmentation by isotope activity type and end-use sectors, including healthcare, industrial, agricultural, and scientific research applications.

More than 45 countries with active cobalt isotope usage are assessed to identify regulatory trends, infrastructure investments, and healthcare modernization initiatives. Approximately 61% of report analysis focuses on medical sterilization and oncology treatment demand due to strong healthcare dependency on gamma irradiation systems. Regional evaluation includes North America, Europe, Asia-Pacific, and Middle East & Africa, covering healthcare facility expansion, food safety regulations, and industrial infrastructure projects. The report also reviews competitive developments among major isotope producers, including reactor modernization programs, automation investments, and advanced source encapsulation technologies. Coverage further includes transportation regulations, radioactive source handling standards, and operational safety improvements influencing long-term market performance.